Cargando…
C-type natriuretic peptide prevents angiotensin II-induced atrial connexin 40 and 43 dysregulation by activating AMP-activated kinase signaling
C-type natriuretic peptide (CNP), from the family of natriuretic peptides (NPs), has been shown to induce antihypertrophic and antifibrotic effects in cardiomyocytes. However, the roles of CNP in the atrial dysregulation of connexin (Cx)40 and Cx43 remain to be elucidated. The present study aimed to...
Autores principales: | Ding, Da-Zhi, Jia, Ya-Nan, Zhang, Bo, Guan, Cheng-Ming, Zhou, Shuai, Li, Xiang, Cui, Xun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854524/ https://www.ncbi.nlm.nih.gov/pubmed/31638216 http://dx.doi.org/10.3892/mmr.2019.10744 |
Ejemplares similares
-
Advanced Glycation End Products Downregulate Connexin 43 and Connexin 40 in Diabetic Atrial Myocytes via the AMPK Pathway
por: Yang, Fan, et al.
Publicado: (2023) -
Atrial AMP-activated protein kinase is critical for prevention of dysregulation of electrical excitability and atrial fibrillation
por: Su, Kevin N., et al.
Publicado: (2022) -
Connexin43 Hemichannel-Mediated Regulation of Connexin43
por: Li, Kai, et al.
Publicado: (2013) -
Connexin 43 reduces susceptibility to sympathetic atrial fibrillation
por: Luo, Beibei, et al.
Publicado: (2021) -
Ser364 of connexin43 and the upregulation of gap junction assembly by cAMP
por: TenBroek, Erica M., et al.
Publicado: (2001)